Stock Events

Stock Events

Design Therapeutics (DSGN) Q2 2023 Earnings

14AugConfirmed

Nov 22

Q4 2022

Q1 2023

Q2 2023

-0.4

-0.36

-0.33

-0.29

Details

Expected EPS

-0.4

Actual EPS

-0.36

Surprise EPS

0.04

Surprise Percent

+10%

Description

Design Therapeutics (DSGN) has reported earnings of -0.36 per share for Q2 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.